Copyright © 2014 American Chemical Society
 

November 24, 2014 Issue

Volume 92, Issue 47
09247-cover-linecxd
November 24, 2014 Issue, Vol. 92 | Iss. 47
Although process analytical technology is finding a home in drug manufacturing, progress is slow
By Ann M. Thayer
(pp. 8-12)
Features
Government & Policy
NIH, NSF seek to make selection process less burdensome, more fair (pp. 21-22)
Science & Technology
Chemists in secretive X labs take a shot at preventive health (pp. 26-28)
Back Issues
 

News of the Week

Nelson Wins ACS President-Elect

ACS News: Board directors are also selected in society’s annual elections
(p.3)

Four Killed At DuPont Plant

Industrial Accident: Methyl mercaptan leak appears to be responsible for deaths
(p.4)

Twisted By Design

Materials Synthesis: Polarized light helps nanoparticles self-assemble into ribbons of controllable chirality
(p.4)

Actavis Wins Bid To Buy Allergan

Pharmaceuticals: Botox maker avoids takeover by Valeant, sealing deal to preserve more of its R&D
(p.5)

Eye Test Might One Day Diagnose Alzheimer’s Before Symptoms Appear

Neuroscience: Imaging method spots disease peptide in mouse retinas
(p.6)

Tufts Study Finds Big Rise 
In Cost Of Drug Development


Pharmaceuticals: Benchmark report sees the cost of bringing a drug to market approaching $3 billion
(p.6)

Arrays Aid Scale-Up Of Drug-Candidate Syntheses

Drug Discovery: Researchers optimize syntheses by adapting coupling reactions in array format
(p.7)

Cystic Fibrosis Foundation 
Gets $3.3 Billion For Royalties


Venture Philanthropy: Payment from Royalty Pharma marks maturation of venture philanthropy model
(p.7)
 

Departments